These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 24516489

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.
    El Amrousy D, Abdelhai D, Shawky D.
    Eur J Pediatr; 2022 Feb; 181(2):579-586. PubMed ID: 34459959
    [Abstract] [Full Text] [Related]

  • 3. The Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease.
    Pezeshki A, Safi S, Feizi A, Askari G, Karami F.
    Int J Prev Med; 2016 Feb; 7():28. PubMed ID: 26955458
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Alami F, Alizadeh M, Shateri K.
    Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
    [Abstract] [Full Text] [Related]

  • 8. [Electroacupuncture combined with lifestyle control on obese nonalcoholic fatty liver disease: a randomized controlled trial].
    Dong C, Zhang CR, Xue BY, Miu WF, Fang NY, Li K, Ou ZJ, Xu YQ.
    Zhongguo Zhen Jiu; 2020 Feb 12; 40(2):129-34. PubMed ID: 32100496
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial.
    Izadi F, Farrokhzad A, Tamizifar B, Tarrahi MJ, Entezari MH.
    Phytother Res; 2021 Jan 12; 35(1):477-485. PubMed ID: 32909326
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Efficacy of Plantago major Seed on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial.
    Jazayeri SF, Ghods R, Hashem Dabaghian F, Shojaii A, Moravej SAA, Khadem E, Seyedian SS.
    Evid Based Complement Alternat Med; 2021 Jan 12; 2021():6693887. PubMed ID: 33854559
    [Abstract] [Full Text] [Related]

  • 16. The effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial.
    Jamali R, Mofid A, Vahedi H, Farzaneh R, Dowlatshahi S.
    Hepat Mon; 2013 Jan 12; 13(12):e14679. PubMed ID: 24358044
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.
    Asghari S, Asghari-Jafarabadi M, Somi MH, Ghavami SM, Rafraf M.
    J Am Coll Nutr; 2018 Jan 12; 37(3):223-233. PubMed ID: 29313746
    [Abstract] [Full Text] [Related]

  • 18. Effect of rosemary leaf powder with weight loss diet on lipid profile, glycemic status, and liver enzymes in patients with nonalcoholic fatty liver disease: A randomized, double-blind clinical trial.
    Akbari S, Sohouli MH, Ebrahimzadeh S, Ghanaei FM, Hosseini AF, Aryaeian N.
    Phytother Res; 2022 May 12; 36(5):2186-2196. PubMed ID: 35318738
    [Abstract] [Full Text] [Related]

  • 19. Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
    Namkhah Z, Naeini F, Mahdi Rezayat S, Mehdi Yaseri, Mansouri S, Javad Hosseinzadeh-Attar M.
    Int J Clin Pract; 2021 Nov 12; 75(11):e14852. PubMed ID: 34516703
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.